KYNMOBI for the Treatment of OFF episodes in Parkinson’s Disease

Image 1-KYNMOBI (apomorphine hydrochloride)
KYNMOBI™ is a non-ergoline agonist of dopamine with a maximum dose of 30mg. Credit: Sunovion Pharmaceuticals Inc.